-
Much more accurate readings than $Dexcom.
-
Cheaper than Dexcom ($DXCM)
-
Colaboration with Ascensia.
-
Growing diabetes markets.
-
Big uncaptured diabetic markets.
-
More freedom compared to competitors.
-
Big Catalysts to come : FDA180 days Device and 365 days while $Dexcom is 7 to 9 days.
-
Extremely undervalued Diabetes company.
-
Stocks to be much more Expendable, much more Bombing,much more Explosive and much more Lucrative for investment.
-
Compare the market cap between $SENS and $DXCM : $1.273B vs $38.26B.
-
$SENS to overwhelm $DXCM in 2(two) years because of "Unprecedented and Unique Diabetes management systems and its demonstrated and proven #1 quality levels of Accuracy.
-
Big Institutions by about 140 ea to back up $SENS strongly : Gilder Gagnon Howe & Co Llc, NEA Management Company, LLC, Delphi Management Partners VIII, L.L.C., Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, BlackRock Inc., VEXMX - Vanguard Extended Market Index Fund Investor Shares, Masters Capital Management Llc, Pura Vida Investments, Llc, and Millennium Management Llc, and George Soros Fund Management WHICH is one of Legendary Hedge funds investors!
-
Cost covered by Aetna, BlueCross/BlueShield, blue California, Horizon NJ Health, TRICARE, U.S. Department of Veterans Affairs, HCSC, Humana, hmsa, Cigna, AmeriHealth, HIGHMARK, MOLINA HEALTHCARE, CareFirst Premera, Independence, and Medicare.
For more information, check here.
Submitted March 01, 2021 at 01:22AM by DougPenhall https://ift.tt/2ZXAqRN
